Share

January 05, 2021; 96 (1) Opinion and Special Articles

Opinion and Special Articles: Remote Evaluation of Acute Vertigo

Strategies and Technological Considerations

Kemar E. Green, Jacob M. Pogson, Jorge Otero-Millan, Daniel R. Gold, Nana Tevzadze, Ali S. Saber Tehrani, David S. Zee, David E. Newman-Toker, Amir Kheradmand
First published October 1, 2020, DOI: https://doi.org/10.1212/WNL.0000000000010980
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1366

Share

This article has a correction. Please see:

Article Information

vol. 96 no. 1 34-38
DOI: 
https://doi.org/10.1212/WNL.0000000000010980
PubMed: 
33004609
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published October 1, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Kemar E. Green, DO,
    2. Jacob M. Pogson, MClinAud, PhD,
    3. Jorge Otero-Millan, PhD,
    4. Daniel R. Gold, DO,
    5. Nana Tevzadze, MD, PhD,
    6. Ali S. Saber Tehrani, MD,
    7. David S. Zee, MD,
    8. David E. Newman-Toker, MD, PhD and
    9. Amir Kheradmand, MD
  1. Kemar E. Green, DO,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Jacob M. Pogson, MClinAud, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Garnett Passe & Rodney William Memorial Foundation. Contributions from the Lott and Schwerin families.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Jorge Otero-Millan, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Frontiers in Systems Neuroscience, Associate Editor, 1

    Patents:

    1. PLATFORM TO DETECT PATIENT HEALTH CONDITION BASED ON IMAGES OF PHYSIOLOGICAL ACTIVITY OF A PATIENT, 62/883,373

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NEI K99EY027846, PI, 5

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Daniel R. Gold, DO,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Current Treatment Options in Neurology co-section editor neuro-ophthalmology and otology, 2014-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. consultation work for WellPoint Insurance -providing neurological input on their quality-based physician rules

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Nana Tevzadze, MD, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Ali S. Saber Tehrani, MD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. David S. Zee, MD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Abbott laboratories, honorarium for teaching

    Editorial Boards:

    1. (1) The Cerebellum, editorial board, 2001-current (2) Frontiers of Neuro-otology (2010-current) associate editor (3) Italian journal of Neurology, editorial board (2010- current

    Patents:

    1. (1) Magnetic field stimulator of the labyrinth

    Publishing Royalties:

    1. (1) The Neurology of Eye Movements, Oxford University Press, 2015

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIDCD, U01-DC01378, COPI, 2015-2020

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Leon-Levy Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. David E. Newman-Toker, MD, PhD and
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Society to Improve Diagnosis in Medicine, travel

    Editorial Boards:

    1. (1) Diagnosis (DeGruyter), Editorial Board Member, April 2014 to present

    Patents:

    1. (1) Eye movement-based diagnosis using mobile phones (provisional patent 2019)

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Medicolegal consulting (expert witness testimony for individual patients) related to dizziness/stroke

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. (1) Lammico, payment for recording CME video about dizziness and stroke misdiagnosis

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Natus Otometrics (video oculography recording equipment loaned for research purposes; non-gift; no other financial interest in this company), (2) Interacoustics (video oculography recording equipment loaned for research purposes; non-gift; no other financial interest in this company)

    Research Support, Government Entities:

    1. (1) NIH/NIDCD, U01 (1U01DC013778-01A1), PI, 2014- 2019 (2) NIH/NCATS, U24TR0016309-01, Co-I, 2016-present (3) NIH/NINDS, U01 (NS080824-01A1), Co-I, 2014-2018 (4) AHRQ, R13HS019252, PI, 2010-2013 (5) AHRQ, HS017755-01, PI, 2008-2010 (6) NIH/NCRR, 1K23RR17324-01, PI, 2002-2009

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Society to Improve Diagnosis in Medicine (2) Gordon & Betty Moore Foundation (3) Patient Centered Outcomes Research Institute (PCORI) (4) Coverys Community Healthcare Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. (1) Eye-movement-based algorithms for stroke diagnosis, GN Otometrics (single payment for license option 2017)

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Amir Kheradmand, MD
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology (K.E.G., J.M.P., J.O.-M., D.R.G., N.T., A.S.S.T., D.S.Z., D.E.N.-T., A.K.), Otolaryngology–Head and Neck Surgery (D.R.G., D.S.Z., D.E.N.-T., A.K.), Ophthalmology (D.R.G., D.S.Z., D.E.N.-T.), Emergency Medicine (D.R.G.), Neurosurgery & Medicine (D.R.G.), and Neuroscience (D.S.Z.), The Johns Hopkins University School of Medicine, Baltimore, MD; and School of Optometry (J.O.-M.), University of California, Berkeley.
  1. Correspondence
    Dr. Green kgreen66{at}jhmi.edu
View Full Text

Article usage

Article usage: October 2020 to February 2023

AbstractFullPdfSource
Oct 20206700556Highwire
Nov 202095050Highwire
Dec 20203384952Highwire
Jan 202146511078Highwire
Feb 20213524329Highwire
Mar 20211493621Highwire
Apr 20211221513Highwire
May 2021177947Highwire
Jun 2021266038Highwire
Jul 2021274635Highwire
Aug 2021136243Highwire
Sep 20212335724Highwire
Oct 2021168377Highwire
Nov 2021156543Highwire
Dec 2021134525Highwire
Jan 2022303432Highwire
Feb 2022205523Highwire
Mar 2022126022Highwire
Apr 202234517Highwire
May 202255320Highwire
Jun 202271712Highwire
Jul 202262415Highwire
Aug 202262116Highwire
Sep 202252717Highwire
Oct 202256023Highwire
Nov 202261427Highwire
Dec 202261811Highwire
Jan 202363113Highwire
Feb 202351247Highwire

Cited By...

Letters: Rapid online correspondence

  • Author Response: Opinion and Special Articles: Remote Evaluation of Acute Vertigo Strategies and Technological Considerations
    • Kemar E. Green, Assistant Professor of Neurology, Johns Hopkins University School of Medicine
    • Jacob M. Pogson, Postdoctoral Fellow, Audiologist, Johns Hopkins University School of Medicine
    • Jorge Otero-Millan, Assistant Professor of Optometry & Visual Science, University of California- Berkeley School of Optometry
    • Daniel R Gold, Associate Professor of Neurology, Ophthalmology, Neurosurgery, Otolaryngology, Emergency Medicine & Internal Medicine, Johns Hopkins University School of Medicine
    • Nana Tevzadze, Otoneurologist, Johns Hopkins University School of Medicine
    • Ali S Saber Tehrani, Assistant Professor of Neurology, Johns Hopkins University School of Medicine
    • David S Zee, Professor of Neurology, Ophthalmology, Otolaryngology & Neurosciences, Johns Hopkins University School of Medicine
    • David E Newman-Toker, Professor of Neurology, Ophthalmology, Otolaryngology & Emergency Medicine, Johns Hopkins University School of Medicine
    • Amir Kheradmand, Professor of Neurology & Otolaryngology, Johns Hopkins University School of Medicine
    Submitted March 18, 2021
  • Reader Response: Opinion and Special Articles: Remote Evaluation of Acute Vertigo: Strategies and Technological Considerations
    • Carsten Tjell, Retired Senior Consultant, Otoneurologist, Otosurgeon and Audiologist, Formerly affiliated to Sorlandet Hospital
    Submitted February 19, 2021
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles